SkinMedica
pioneered the first commercially available cosmetic product made almost entirely of a growth-factor blend with its TNS platform, using Human Fibroblast Conditioned Media in its TNS Advanced+ Serum, clinically positioned for sagging skin.
- Country
- United States
growth-factor-serum
us
Coverage
| US | |
|---|---|
| specialty-fine-chem | ✓ |
Regulatorsfdareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioactive cosmetic peptides & growth factors | specialty-fine-chem | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.